Skip to content

Clinical trials

Terminated Choroidal Neovascularization trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Choroidal Neovascularization Status: Terminated Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20063
20073
20083
20091
20101
20111
20132
20142
20152
20171
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ophthotech Corporation4
Asociación para Evitar la Ceguera en México3
Pfizer2
Santen Inc.2
Allergan1
Barnes Retina Institute1
Center for Eye Research Australia1
Fondation Ophtalmologique Adolphe de Rothschild1
Iconic Therapeutics, Inc.1
Light Sciences LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Choroidal Neovascularization23
Macular Degeneration18
Angioid Streaks1
Neovascularization, Pathologic1
Polypoidal Choroidal Vasculopathy1
Wet Macular Degeneration1

Trials

Showing 26 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.